AiDot offers smart home devices and solutions for lighting, security, and small appliances, aimed at simplifying daily life.

AiDot

AiDot specializes in smart home devices, focusing on lighting, security, small appliances, and automation solutions. It aims to simplify daily life through innovative technology.

AIDOT Inc. | 215 followers on LinkedIn. AIDOT develops medical software using AI. Their flagship product makes cervical cancer screening faster, easier and more | AIDOT is a leading company specialized in artificial intelligence based medical and healthcare solution. 
We are developing and providing innovative solution for creating a better world for human.

Strategy | Business Development | AI Healthcare | M&A | Sustainability | ESG | Nanotech | Consulting |

Charlie Moon

재무( 연결 결산 회계 금융 법인관리 ) AICPA

JUNG BOK LEE

Global sales and marketing

Garam Lim

AI Engineer

Dongwoo Ko

AIDOT Inc.

We’re pleased to share the launch of the “Cervical Cancer Free Umnugobi” initiated by our partner in Mongolia. This initiative aims to enhance women’s health in the Gobi region of Mongolia. Building on the “Test for Life” program, which has benefited over 40,000 women since 2005, a mobile clinic equipped with our AI-based cervical cancer screening technology will be deployed. This will help ensure early detection and better access to care in underserved rural communities. Our goal is to make a meaningful impact on cervical cancer prevention and screening in Mongolia, working toward a healthier future for women in the Gobi region. #TestForLifeGobi2024 #CervicalCancer #AI #AIDOT

Cervical cancer is the second most common cancer in the world. Early detection is key, and with our AI, it's more accessible than ever. In just a couple minutes, our artificial intelligent technology analyzes your results swiftly and accurately. No more waiting or uncomfortable procedures! 😌 Spread the word and join us in revolutionizing cervical cancer screening! 😄 #CervirayAI #Cerviray #Colposcope #Cervicography #Cervicalcancer #Screening https://lnkd.in/gutQHChx

We, AIDOT, are going to Bolivia for attending the event of prevention of cervical cancer!! See you all in Bolivia!! #Prevention #Cervicalcancer #Cerviray #CervirayAI #Artificialintelligence #with #KOICA #MSI #TRIAR #Bolivia

AIDOT announced that on April 16th, the United States Patent and Trademark Office granted a patent for AIDOT’s Artificial Intelligence-based ‘Cervical Cancer Automated Diagnosis System’. This patent pertains to an artificial intelligence-based cervical cancer automated diagnosis system, which classifies and machine-learns the cervical data required for automatic diagnosis of cervical cancer based on accurate criteria, and diagnoses cervical cancer based on the machine learning. Since completing domestic patent registration in 2021, AIDOT has also completed patent registration in Japan, China, and Indonesia, and has filed applications in other major market countries. The registration of this US patent demonstrates both a market-leading achievement of AIDOT's artificial intelligence technology in the US and a global recognition of its advanced technology. Particularly, the broad scope of the claims in this patent has significantly raised barriers to entry for latecomers, resulting in significant technology protection. AIDOT CEO Jung Jae-hoon stated, "Already, Cerviray A.I. has received FDA 510K approval and confirmed the possibility of insurance claims through CPT application in the US, and with this newly registered US patent, Cerviray A.I.'s competitiveness in the US market has been further strengthened as the second US patent following the 'Cervical Image Acquisition Device' registered in January." He continued, "The fact that an AI medical device developed in Korea has been recognized for its commercial viability and practicality in the US market is meaningful. We have agreed to achieve tangible results through detailed discussions with our US partner." #AIDOT #HealthTech #Innovation #AI #CervicalCancer #PatentGranted

Exciting News from AIDOT! Our gastrointestinal endoscopy real-time screening AI solution, 'GIGA dot AI,' has been designated as an innovative medical device by the Ministry of Food and Drug Safety (MFDS) on 22nd of May! It has been designated as Advanced Technology Group No. 63. Innovative medical devices designated by the MFDS are those that have significantly improved or are expected to improve safety and efficacy compared to existing medical devices or treatment methods through the application or improvement of advanced technologies in fields with high technological intensity and rapid innovation, such as information and communication technology, biotechnology, and robotics. These devices are designated under Article 21 of the 'Medical Device Industry Promotion and Innovative Medical Device Support Act.' Last year, this AI solution obtained a Class 3 medical device product license in South Korea. GIGA dot AI features real-time, rapid analysis of the location and severity of lesions by receiving video input from gastroscopy and displaying the information on the screen. The software accurately identifies and locates six severity levels (AGC, EGC(SM), EGC(M), HGD, LGD, Non-neoplasm). GIGA dot AI is expected to enhance early detection and treatment opportunities for gastric cancer, reduce costs, assist in determining the feasibility of endoscopic resection, and improve diagnostic accuracy without the need for endoscopic ultrasound. This innovation will also boost the efficiency of medical resources. Stay tuned for more updates on GIGA dot AI as we continue to innovate and improve healthcare technology! #AIDOT #GIGAdotAI #MedicalInnovation #MedicalAI #GastrointestinalHealth #EarlyDetection #GastricCancer #HealthTech

We’re excited to announce that we've secured a patent in Vietnam for Cerviray A.I.! This groundbreaking technology will revolutionize cervical cancer screening, enhancing early detection and diagnosis for better women's health outcomes across Vietnam. This patent solidifies our presence in Vietnam’s rapidly growing healthcare market, reinforcing our role as a leader in innovative healthcare solutions. We're now focused on bringing this technology to market, working closely with local partners to ensure it benefits those who need it most. Let's celebrate this milestone and the impact we're making in healthcare! #Innovation #Healthcare #Vietnam #CervirayAI #AIDOT

On July 16, AIDOT took a significant step in advancing healthcare in Vietnam by signing an agreement to provide key hospitals with our AI cervical cancer screening system, Cerviray A.I. Through this partnership, facilitated by the Gangwon-do Vietnam office and VKCI, we're offering Cerviray devices and software to major Vietnamese hospitals FREE of charge. Our goal is to increase cervical cancer screening rates, ensuring more women receive regular check-ups. The signing ceremony, held at the New World Saigon Hotel during the "2024 Korea-Vietnam Partnership Plus Week," was a notable event with 150 key figures from both Korea and Vietnam's governments, businesses, and media in attendance. The event also featured the "Gangwon-do AI Solutions Seminar," introducing Cerviray A.I. to provincial officials and medical staff. AIDOT is dedicated to improving women's health worldwide with our AI solutions. Together, we can make a difference! 🌍✨ #HealthcareInnovation #AI #CervicalCancerScreening #Vietnam #AIDOT #CervirayAI #WomensHealth #KoreaVietnamPartnership #MedicalDonation

Our innovative AI-based cervical cancer remote screening system, Cerviray A.I., will be introduced at the upcoming Asia-Oceania Research Organization in Genital Infection and Neoplasia (AOGIN) 2024. On July 12th at 4 PM Professor Kim Sung-min from the Ilsan CHA Hospital Gynecologic Oncology Center will present on the "Efficacy and Safety of Artificial Intelligence-based Cervical Image Diagnosis Aid Software," highlighting Cerviray AI. Professor Kim will discuss how Cerviray AI provides new opportunities for women in regions where regular screenings are not available. It serves as a reliable tool for both trained and untrained colposcopists, aiding in the identification and diagnosis of cervical lesions and guiding biopsy locations for high-grade lesion diagnosis. AOGIN, established in 2004, is an international conference that includes 25 member countries from Asia and Oceania. The organization focuses on the prevention and treatment of female genital infections and cancers. This year’s conference, themed "Empowering Women, Together against Cervical Cancer," is expected to attract around 500 doctors and researchers who will discuss the latest advancements in early cancer detection, prevention, and treatment. Cerviray is currently moving towards commercialization through partnerships in 14 countries. This rapid adoption is helping to improve women's health, particularly in areas with limited medical infrastructure. AIDOT is dedicated to using advanced AI technology to enhance women's health worldwide, continuously developing solutions for underserved communities. Stay tuned for more updates from AIDOT! #CervirayAI #AOGIN2024 #MedicalInnovation #AIDOT

AIDO

COM:AIDOT

AiDot